Patent details

Basic Information

Publication number:

LUC50032

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP177459518

Legal Status:

Pending & Published

Application number:

LUC50032

First applicant's nationality:

Procedural language:

English

Marketing Authorization

Marketing Authorization Number:

EU/1/23/1748

Marketing Authorization Type:

Marketing Authorization Date:

22/08/2023

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

12/01/2026

First Marketing Authorization date:

22/08/2023

Grant date:

Activation date:

Publication date:

12/01/2026

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

22/08/2038

SPC Extension Expiration:

22/08/2038

Rejection date:

Withdrawal date:

Owner

From:

12/01/2026

 

 

Name:

Janssen Biotech, Inc.

Address:

800/850 Ridgeview Drive, Horsham, PA 19044, United States (US)

Agent

Name:

Dennemeyer & Associates S.A.

From:

12/01/2026

Address:

55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)

To:

Publication

Bulletin

Bulletin Heading:

SPC1

Bulletin edition number:

2026/03

Publication date:

05/02/2026

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

Annual Fees

Annual Fee Due Date:

31/07/2037

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
12/01/2026	Application Form	5
12/01/2026	General Document	2
12/01/2026	General Document	50
12/01/2026	General Document	5
12/01/2026	Outgoing Correspondence	2
12/01/2026	General Document	1
12/01/2026	Publication	1
12/01/2026	Outgoing Correspondence	1
12/01/2026	Marketing authorization	3
12/01/2026	MA publication	9